Objectives: Cumulus cells play a crucial role as essential mediators in the maturation of ova. Ginger contains 10-gingerol, which induces apoptosis in colon cancer cells. Based on this hypothesis, this study aimed to determine whether 10-gingerol is able to induce apoptosis in normal cells, namely, cumulus cells.
and transporting them through gap junctions for oocyte maturation stimuli. 5 The role of the cumulus cell is an essential mediator for ovulation stimuli. 6 Prevention of ovulation is a major target mechanism of oral contraceptives. 7 The use of these contraceptives often results in side effects for their acceptor, from general conditions, such as obesity, 8 to serious cases, such as breast, cervical, endometrial, or colorectal cancer. 9 Therefore, we need to uncover an agent, such as ginger, which contains 10-gingerol, as a candidate contraception agent.
Since ancient times, ginger has been used as a traditional drug without side effects. 10, 11 The herbal drug ginger (Zingiber officinale Roscoe) is rich in various pharmacological properties, including antioxidant, 12 antiinflammatory, 13 and anti-cancer 11, 14 activities through the activation of p-53 to induce apoptosis. 15, 16 Bioactive compounds of ginger induce apoptosis to suppress ovarian cancer cell proliferation. 17 Terpenoid of ginger alters the Bax/Bcl-2 ratio to induce apoptosis in MDA-MB-231 human breast cancer cells 18 followed by a down regulation of cellular pro-caspase 3. 19 A minor bioactive component in fresh ginger is shogaols, 20 which induces apoptosis through the up-regulation of p-53 and the down-regulation of B cell lymphoma-2 (Bcl-2) followed by cytochrome Complex (cyt c) release, perturbation of apoptosis proteins and activation of caspase 9 and 3. 21 Fresh ginger also contains gingerols, such as 6-gingerol, 8-gingerol, and 10-gingerol, which are major biologically active components. 22 6-Gingerol has various pharmacological functions and exhibits anti-proliferative and pro-apoptotic activities. 23 In MDA-MB-231 breast cancer cells, 8-gingerol and 10-gingerol are pro-apoptotic and anti-proliferative. 24 In HL-60 human leukaemia cells, 10-gingerol is anti-carcinogenic and kills cells at concentrations of 10e100 mM, which is better than 6-gingerol. 25 In HCT 116 and HT 29 colon cancer cell lines, the bioactive molecules in ginger act as anti-tumour agents by inducing apoptosis. 26 In HCT 116 colon cancer cells, 10-gingerol inhibits cell proliferation through the induction of mitochondrial apoptosis. 27 Recently, a study reported that 10-gingerol was more potent than 6-gingerol and 8-gingerol for the inhibition of mammary carcinoma cell growth through the induction of apoptosis. 28 The bioactive compound in ginger can interact with a receptor of serotonin, HTR1A.
29 HTR1A has anti-apoptotic properties 30 and is implicated in cell survival. 31 HTR1A is found in cumulus cells and plays a crucial role in the regulation of cell proliferation, 32 which is inhibited by an antagonist of HTR1A.
33 HTR1A functions are disturbed by a ligand inhibitor, H1C1. 34 Gingerols are major compounds in ginger, which exhibit anti-cancer effects through degradation of the GSK3B pathway. 35 The GSK3B has positive functions, which are related to the regulation of numerous cellular functions, including cell growth 36 and cell cycle, 37 whereas the negative functions of GSK3B are related to the regulation of the expression of p-53 to induce apoptosis. 38 10-Gingerol inactivates AKT to regulate down regulate the cell cycle process in MDA-MB-231 breast cancer cells and inhibit their proliferation. 39 The AKT inactivation is associated with cell death. 40 AKT is a serine/threonine-specific protein kinase that is a mediator through the PI3K/AKT pathway in biological processes, such as cell proliferation, survival cell, 41 cell cycle, 42 and apoptosis. 43 Apoptosis is the process of programmed cell death, which can occur either through the extrinsic pathway, which is characterized as death receptormediated, 44 and the intrinsic pathway, which is influenced by members of the bcl family (bax and bcl-2) to act as proor anti-apoptotic factors depend on the regulatory proteins. 45 The activation of pro-apoptotic proteins, such as FOXO- 1 46 , FOXO-3, 47 and PTEN, 48 and the inactivation of anti-apoptotic proteins, such as ILK, 49 MDM2, 50 NOS3, 51 mTOR, 52 and RICTOR, 53, 54 leads to apoptosis. During apoptosis, phospholipid phosphatidylserine residues are translocated from the inner to the outer leaflet of the plasma membrane. 55 In this case, phosphatidylserine binds to the protein Annexin-V when it is labelled with a fluorescent FITC tag, which detects apoptosis. 56 Increased apoptosis in cumulus cells is an indicator that decreases the quality of the oocyte, which contributes to a decrease in the percentage of oocyte maturation. 57 The oocytes maturation rate is higher in oocytes with the cumulus cells than in oocytes without the cumulus cells. 58 The relationship between the cumulus cells and the oocyte is important, not only in oocyte maturation but also for secreting chemotactic factors that guide the spermatozoon to the oocyte, which increases the chance of fertilization. 59 To gain information about its side effects when it is applied for cancer treatment, we attempted to investigate the effects of 10-gingerol, a bioactive compound of ginger on cumulus cells. While the anti-carcinogenic property of 10-gingerol has been reported previously, this study is the first to investigate the effects of 10-gingerol on normal cumulus cells.
Materials and Methods
These studies obtained ethical approval from the Health Research Ethics Committee at the Medical Faculty of Brawijaya University in Malang, East Java, Indonesia No. 588/ EC/KEPK/11/2014.
Isolation of cumulus cells
The ovaries of a goat were obtained from an abattoir and were saved in 0.9% NaCl at 34e37 C. The cumulus cells were released from 3 to 5 mm ovarian follicles using a 21 Gx1.5 in needle, were diluted with 1 mL of M199 (Sigma) and were centrifuged for 5 min. The supernatant was put aside, and then, 1 mL of fresh M199 (Sigma) was added.
Cumulus cell culture and harvesting
The cumulus cells were cultured using M199 in four composition mediums consisting of 20 mM high D-glucose (Merck) as a control and three combinations (i.e., the high glucose medium contained 10-gingerol (Aphios) in various concentrations (12, 16 , and 20 mM)) as treatments. The cells were incubated for 24, 48, 72, and 96 h in a humidified atmosphere of 5% CO 2 at 37 C. The cumulus cells were harvested using trypsineEDTA (Sigma).
Detection of apoptosis in cumulus cells
The cumulus cells were harvested, washed using cold Biolegend cell staining buffer, and resuspended in Annexin V binding buffer, and 100 mL of the cell suspension was transferred and added to 5 mL of fluorochromes into the conjugated Annexin V-FITC. Then, 10 mL of the PI solution was added, and it was incubated for 15 min at 25 C in the dark room. Next, we added 400 mL of the Annexin V binding buffer and analysed the samples using Flow Cytometry. The data are presented as dot plots (Annexin V-FITC plotted against PI staining). Apoptosis was determined based on the Annexin V-FITC positive cumulus cells (i.e., UR (upright) þ LR (low right)).
Prediction target and pathway analysis of 10-gingerol using a bioinformatics approach
The protein targets of 10-gingerol were assessed using SwissTarget (http://swisstargetprediction.ch). We found HTR1A as a protein target of the compound (at 90% probability). The three-dimensional structure (3D) of HTR1A was modelled using homology modelling (SWISS-MODEL) based on a protein template (PDB 2JOA). The 3D model was used to examine the binding between HTR1A and 10-gingerol. The interaction between the both molecules was analysed using AutoDock Vina in the PyRx 0.8 Program.
The results of the docking were visualized using BIOVIA 1 Discovery Studio 2016'-Accelrys (San Diego, CA, USA). Furthermore, we explored the function of HTR1A through the STRING database (http://string-db.org/newstring).
Statistical analysis
This experiment consisted of 16 combination treatments, and all treatments were performed at least two times. The statistical significance of apoptosis in the cumulus cells was determined using a two-way analysis of variance (ANOVA) test using the SPSS 16 programme. The results were presented as the mean AE standard deviation (SD) in the histogram.
Results
The result of the in vitro study showed that apoptosis in the cumulus cells was minimal and was statistically significant only at the end of the 96 h incubation period ( Figure 1A4, Table 1, Figure 2 ). The apoptosis percentage in the cumulus cells increased with the 10-gingerol treatment along with the period of incubation. In this case, this was proven by the treatments that were described in the data in Figure 1D1eD4 , Figure 1B4 , C4, D4, Figure 3B ) with a hydrophobicity between À3 and 3 ( Figure 3C ), which indicates that 10-gingerol binds to hydrophobic active sites.
The result of the exploration using the STRING database (http://string-db.org/newstring) suggested that HTR1A functions are linked to various biological process pathways, including regulation of the apoptotic process, the cell cycle process, and the regulation of cell proliferation. The presence of 10-gingerol inhibits HTR1A functions, inactivate GSK3B and AKT-1 to induce apoptosis, and inhibits the cell cycle process and the proliferation of cumulus cells by activating pro-apoptotic proteins, such as FOXO1, FOXO3, and PTEN and inactivating anti-apoptotic proteins, such as NOS3, ILK, MDM2, mTOR, and RICTOR ( Figure 4 ).
Discussion
Details of apoptosis in cumulus cells have been investigated. However, the role of 10-gingerol to induce apoptosis that involves its protein target HTR1A remains unclear. Glucose represents a critical physiological function that provides energy to support cumulus cell proliferation ( Figure 1A1eA4, Table 1, Figure 2 ). Previous researchers have reported that high glucose concentrations promote the proliferation of cells and significantly increase the population of the cells. 60 Higher glucose concentrations produce higher cell populations than lower glucose concentrations. 61 A high glucose concentration (10e50 mM) promotes cell proliferation without any effect on viability. 62 The in-silico study predicted that apoptosis in the cumulus cells, by 10-gingerol, occurred through diffusion on the surface of the cumulus cell membrane and inhibited its protein target or receptor, HTR1A. Furthermore, 10-gingerol crossed the cumulus cell's membrane and damaged the mitochondrial membrane, releasing cytochrome C from the mitochondria to go into the cytosol. Ziegler & Groscurth 63 reported that, in the cytosol, cytochrome C activated pro-caspase 9, 3, 6, and 7. These caspases led to apoptosis in the cumulus cells. 64 In addition, a previous study reported that 10-gingerol is a hydrophobic compound 19 and possesses anti-carcinogenic properties that are better than other gingerols. 25 10-gingerol, a lipophilic compound, inhibits the proliferation of cancer cells and decreases the viability of tumour cell lines, 24 and 10-gingerol induces apoptosis in a cancer cell. 27 10-gingerol is a hydrophobic compound that acts as an inhibitor for HTR1A functions (Figure 3 ) to induce apoptosis (Figure 4) . Previous researchers report that ginger possesses phenolic compounds that can interact with HTR1A.
29
HTR1A stimulates numerous biological processes, such as cell proliferation, 65 growth regulation, 33, 66 anti-apoptosis, 30 Figure 1: Percentage of apoptotic cumulus cells resulting from the 10-gingerol treatment for an incubation period of 24e96 h. The cumulus cells were cultured using 20 mM high glucose medium and high glucose medium contained various concentrations of 10-gingerol for an incubation period of 24e96 h. The induction of apoptotic cumulus cells was investigated using an Annexin V-FITC apoptosis detection kit with a PI solution and was analysed by flow cytometry. The data were presented as dot plots (Annexin V-FITC plotted against PI staining). Apoptosis was determined based on the Annexin V-FITC positive cumulus cells, i.e., UR (Up-Right) þ LR (LowRight). NF-ҡB pathway, 67 modulating cell survival, 31 controlling cell development, 68 cell survival, 67 and cell cycle progression. 69 In contrast, the inactivation of HTR1A, by an inhibitor, disturbs the cell cycle process. 70 The HTR1A that was applied in the insilico study was for the anti-proliferation of ligands. 34 In fact, HTR1A was also found in cumulus cells. 32 The HTR1A acts as a pro-apoptosis agent 43 through the negative role of GSK3B for p-53 expression regulation, 36 which induces apoptosis 38 through AKT inactivation by 10-gingerol 27 and induces G1 phase arrest. 39 The AKT inactivation is associated with cell death 40 and decreases cell proliferation. 71, 72 The inhibition of the AKT pathway acts to enhance the activation of pro-apoptosis proteins, such as FOXOs 73 as tumour suppressors, 74 and their forced expression inhibits cell proliferation. 75 FOXOs (FOXO1 and FOXO3) are important targets of AKT (Figure 4 ) that play a role in promoting cell growth inhibition and apoptosis by inducing the expression of multiple pro-apoptotic proteins, such as the Bcl2, Fas ligand, and tumour necrosis factor-related apoptosisinducing ligand, TRAIL.
76 FOXO1 acts as a tumour suppressor, 77 an anti-proliferative, and a pro-apoptotic gene that might lead to endothelial cell death. 78 The activation of FOXO1 is involved in the regulation of apoptosis, cell proliferation arrest, and decreases cell viability in cervical cancer cell lines and during tumourigenesis. 46 In addition, it acts as a tumour suppressor 79 and function in the process of pro-apoptosis in the follicular granulosa cells of growing follicles. 62, 80 The expression of FOXO1 induces pro-apoptotic pathways and delays the G2/M transition. 81 FOXO3 is a pro-apoptotic molecule that increases in follicular atresia. 47 The inactivation of AKT increases FOXO3a, which is a subfamily of FOXO3 that functions to suppress tumour cell growth. 82 AKT inhibition suppresses cumulus cell expansion, 83 and in pancreatic islet b-cells, it results in a dysfunction that leads to apoptosis through PTEN activation. 84 PTEN is a tumour suppressor that induces apoptosis by activating caspase-3 and caspase-8, 48 inhibiting cell proliferation, 85 and increasing apoptosis. 86 The activation of PTEN activates p53 and their interactions induce apoptosis through the Bax and caspase 3 pathways. 87 PTEN and p53 also form a complex in the nucleus and induce the expression of tumour suppressors, resulting in apoptosis 88 and the induction of cell cycle arrest at the G1 phase to inhibit cell proliferation. The inactivation of AKT inactivates anti-apoptosis proteins, such as NOS3, an enzyme that plays a crucial role in the production of NO. 90 NO is indicated to protect against the effects of free radicals, DNA damage, and impair the tumour suppressor function of p53, which may cause cancer cell development. 91 NO directly inhibits the activity of caspases to obstruct apoptosis by blocking cytochrome C release, increasing Bcl-2 expression, which controls mitochondrial permeability, and playing a role in tumour progression. 92 The absence of AKT-1 enhances apoptosis as a result of the loss of eNOS, which is well known as NOS3. 93 Lower levels of NOS3 result in lower levels of NO, which are associated with poorer cell survival. 94 An altered intracellular generation of NO from NOS-3 induces cell death and arrests cell proliferation in tumour cells. 95 AKT inactivation suppresses ILK expression. 96 ILK is a serineethreonine kinase that is involved in the regulation of cell proliferation. 97 The knockdown of ILK expression induces growth inhibition and apoptosis in ovarian cancer cells. 98 The inhibition of ILK in vivo results in decreased tumour growth through the induction of apoptosis, 49 which induces cell-cycle arrest 99 and proliferative defects. 100 Our in-silico data provides evidence that 10-gingerol is a small molecule inhibitor for the expression of ILK that induces apoptosis in cumulus cells (Figure 4) . Increasing apoptosis by 10-gingerol (Table 1, Figure 2 ) through HTR1A induced the inactivation of AKT and mTOR ( Figure 4 ). The inactivation of both AKT activity and mTOR enhances the apoptotic cell death of granulosa cells, 51 because mTOR is a serine/threonine kinase 101 that plays a critical role as a growth factor in mammals. 102 mTOR is a major downstream target of AKT 52 that form two functionally distinct complexes, which involve mTORC1 and mTORC2. 103, 104 mTORC1 is essential to control protein synthesis and cellular metabolism, while mTORC2 is essential to control cell viability. 105 AKT inhibition, followed by mTORC1 blockage, contributes to anti-tumour responses. 106 The down-regulation of mTORC2 facilitates apoptosis in breast cancer cells. 105 The suppression of mTOR blocks G1 cell cycle progression 107 and inhibits the proliferation of a lymphoma cell line. 108 In addition, the inhibition of the AKT-mTOR pathway leads to the initiation of apoptosis 52 and cell cycle G1 arrest in ovarian cancer cells, 109 which accompanies cell death, 110 resulting in antitumour effects. 111 Apoptosis in cumulus cells is significantly increased by 10-gingerol (Table 1, Figure 2 ). In this case, 10-gingerol inhibits HTR1A functions (Figure 3 ) to suppress RICTOR (Figure 4 ). RICTOR is a cytosolic protein that is recognized as a specific component of mTORC2, which functions to regulate cell proliferation. 101 The loss of RICTOR prevents mTORC2 activation. 112 In addition, the inhibition of RICTOR induces apoptosis to inhibit cell proliferation. 113 Moreover, the loss of RICTOR in oocytes causes follicular apoptotic death, 54 while the deletion Figure 4 : Result of the exploration of HTR1A functions involved in biological process pathways using the STRING database (http://stringdb.org/newstring). The pathway analysis exhibited the regulation of apoptosis, cell cycle process, and proliferation by 10-gingerol through HTR1A in the cumulus cells.
of RICTOR in osteoblasts inhibits osteoblast bone formation. 114 Furthermore, the suppression of RICTOR induces apoptosis in lung cancer cells. 53 Apoptosis in the cumulus cells by 10-gingerol (Figure 1 ), through HTR1A, occurred by inhibiting MDM2 activity, which involved the blockade of AKT (Figure 4) . The inhibition of AKT re-activates the promotion of p-53 function to block MDM2 activity, 115e117 which, thus, induces the apoptotic response and G2/M cell cycle arrest. 118 The inhibition of MDM2 results in the activation of p53 and the induction apoptosis through the activation of caspases 3, 7 and 9. 50 The disruption of the p-53-MDM2 interaction activates the p-53 pathway, resulting in apoptosis, 119 which is cytotoxic to the G1 phase arrest and the anti-proliferative effect. 120 The inactivation of AKT contributes to MDM2 depletion, which, thus, the results in increased apoptosis, cell cycle arrest, and anti-proliferative effects. 121 
Conclusion
This study's results indicate that 10-gingerol induces apoptosis and inhibits the cell cycle process and cell proliferation in cumulus cells through HTR1A, which inactivates the GSK3B protein and the AKT-1 protein. Consequently, this protein activates pro-apoptosis proteins, such as FOXO-1, FOXO-3, and PTEN, and inactivates anti-apoptosis proteins, such as ILK, MDM2, mTOR, NOS3, and RICTOR. Furthermore, ginger extract with 10-gingerol can be further utilized as an alternative contraceptive agent as it prevents oocyte maturation through the cumulus cells death.
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